Evidence map›Paper›PMID 29701767›Full record

ArticleChemical senses2018

Development of Full Sweet, Umami, and Bitter Taste Responsiveness Requires Regulator of G protein Signaling-21 (RGS21).

Adam B Schroer, Joshua D Gross, Shane W Kaski, Kim Wix, David P Siderovski, Aurelie Vandenbeuch, Vincent Setola

Open access · bronzeAbstract read
In one paragraph

Article in Chemical senses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Sweet Taste Signaling: The Core Pathways and Regulatory Mechanisms.International journal of molecular sciences · 2022
    Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Adam B SchroerDepartment of Physiology, Pharmacology, and Neuroscience, West Virginia School of Medicine, One Medical Center Drive, Morgantown, WV, USA.
Joshua D GrossDepartment of Physiology, Pharmacology, and Neuroscience, West Virginia School of Medicine, One Medical Center Drive, Morgantown, WV, USA.
Shane W KaskiDepartment of Physiology, Pharmacology, and Neuroscience, West Virginia School of Medicine, One Medical Center Drive, Morgantown, WV, USA.
Kim WixDepartment of Physiology, Pharmacology, and Neuroscience, West Virginia School of Medicine, One Medical Center Drive, Morgantown, WV, USA.
David P SiderovskiDepartment of Physiology, Pharmacology, and Neuroscience, West Virginia School of Medicine, One Medical Center Drive, Morgantown, WV, USA.
Aurelie VandenbeuchDepartment of Otolaryngology, University of Colorado - Denver, Anschutz Medical Campus, Aurora, CO, USA.
Vincent SetolaDepartment of Physiology, Pharmacology, and Neuroscience, West Virginia School of Medicine, One Medical Center Drive, Morgantown, WV, USA.
West Virginia University · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Tecan EVO GenePaint robotS10OD016167 · OD · BAYLOR COLLEGE OF MEDICINE · PI LJUNGBERG, CECILIA · 2013 to 2013
$215k
The role of RGS12 in the action of amphetamine and related drugs of abuseF31DA043331 · NIDA · WEST VIRGINIA UNIVERSITY · PI GROSS, JOSHUA D · 2017 to 2018
$88k
NIH HHS S10 OD016167
6 · The paper itself

Abstract

The mammalian tastes of sweet, umami, and bitter are initiated by activation of G protein-coupled receptors (GPCRs) of the T1R and T2R families on taste receptor cells. GPCRs signal via nucleotide exchange and hydrolysis, the latter hastened by GTPase-accelerating proteins (GAPs) that include the Regulators of G protein Signaling (RGS) protein family. We previously reported that RGS21, uniquely expressed in Type II taste receptor cells, decreases the potency of bitter-stimulated T2R signaling in cultured cells, consistent with its in vitro GAP activity. However, the role of RGS21 in organismal responses to GPCR-mediated tastants was not established. Here, we characterized mice lacking the Rgs21 fifth exon. Eliminating Rgs21 expression had no effect on body mass accumulation (a measure of alimentation), fungiform papillae number and morphology, circumvallate papillae morphology, and taste bud number. Two-bottle preference tests, however, revealed that Rgs21-null mice have blunted aversion to quinine and denatonium, and blunted preference for monosodium glutamate, the sweeteners sucrose and SC45647, and (surprisingly) NaCl. Observed reductions in GPCR-mediated tastant responses upon Rgs21 loss are opposite to original expectations, given that loss of RGS21-a GPCR signaling negative regulator-should lead to increased responsiveness to tastant-mediated GPCR signaling (all else being equal). Yet, reduced organismal tastant responses are consistent with observations of reduced chorda tympani nerve recordings in Rgs21-null mice. Reduced tastant-mediated responses and behaviors exhibited by adult mice lacking Rgs21 expression since birth have thus revealed an underappreciated requirement for a GPCR GAP to establish the full character of tastant signaling.

Indexed as

Food PreferencesTasteAnimalsMiceMice, Inbred C57BLMice, KnockoutRGS ProteinsRGS Proteins

Identifiers

PMID29701767
PMCPMC6276893
OpenAlexW2799585145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.